Teva- Pharmaceutical Industries Ltd
NYSE: TEVA
$17.43
-$1.34 (-7.1%)
Closing Price on November 6, 2024
TEVA Articles
Rite Aid, Valeant, Calpine, and Teva all posted new 52-week lows on Thursday.
Published:
Last Updated:
Valeant, Arena, Teva, and Frontier Communications all posted new 52-week lows on Tuesday.
Published:
Last Updated:
Cenovus Energy, DryShips, Teva Pharmaceuticals, and OncoMed Pharmaceuticals all posted new 52-week lows Wednesday.
Published:
Last Updated:
The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of these selected pharmaceutical stocks.
Published:
Last Updated:
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Tuesday’s top analyst upgrades, downgrades and initiations include Apple, CVS Health, Priceline, Teva Pharmaceutical and Workday.
Published:
Last Updated:
Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.
Published:
Last Updated:
After Teva Pharmaceutical International reported fourth-quarter and full-year 2016 on Monday, only a few analysts weighed in initially, but the consensus is slowly growing more negative.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday include Intuitive Surgical, Restaurant Brands, Scorpio Tankers, Teva Pharmaceutical, Under Armour and Zillow.
Published:
Last Updated:
Teva beat estimates on earnings and revenues for both the quarter and the fiscal year and its outlook for 2017 is better than the consensus estimates.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Cisco, Pepsico and some of the other most anticipated quarterly earnings reports expected this coming week.
Published:
Last Updated:
Stocks were indicated marginally higher on Friday morning on what seems to be a very light news day. The Dow is still above 20,000 and the S&P 500 has gone above the 2,300 level. Even though the...
Published:
Last Updated:
It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far the reaction has been quite positive.
Published:
Last Updated:
Gilead Sciences, Gale Biopharma, Teva, and Fitbit post new 52-week lows Wednesday.
Published:
Last Updated: